APA (7th ed.) Citation

N, A., Z, S., DS, H., RJ, G., V, W., LM, M., . . . KT, F. (2026). Larotrectinib in Patients With Tumors With NTRK Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-Z1E. JCO precision oncology, 10, e2500612. https://doi.org/10.1200/PO-25-00612

Chicago Style (17th ed.) Citation

N, Akhave, et al. "Larotrectinib in Patients With Tumors With NTRK Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-Z1E." JCO Precision Oncology 10 (2026): e2500612. https://doi.org/10.1200/PO-25-00612.

MLA (9th ed.) Citation

N, Akhave, et al. "Larotrectinib in Patients With Tumors With NTRK Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-Z1E." JCO Precision Oncology, vol. 10, 2026, p. e2500612, https://doi.org/10.1200/PO-25-00612.